These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23157545)

  • 1. The development of antibody-based immunotherapy for methamphetamine abuse: immunization, and virus-mediated gene transfer approaches.
    Chen YH; Chen CH
    Curr Gene Ther; 2013 Feb; 13(1):39-50. PubMed ID: 23157545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of methamphetamine abuse: an antibody-based immunotherapy approach.
    Chen YH; Wu KL; Tsai HM; Chen CH
    J Food Drug Anal; 2013 Dec; 21(4):S82-S86. PubMed ID: 26334109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of active and passive human vaccines to treat methamphetamine addiction.
    Gentry WB; Rüedi-Bettschen D; Owens SM
    Hum Vaccin; 2009 Apr; 5(4):206-13. PubMed ID: 19276653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for the treatment of drug abuse.
    Kosten T; Owens SM
    Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.
    Owens SM; Atchley WT; Hambuchen MD; Peterson EC; Gentry WB
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):892-8. PubMed ID: 22229314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapies for drug addictions].
    Montoya I
    Adicciones; 2008; 20(2):111-5. PubMed ID: 18551223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice.
    Chen YH; Wu KJ; Wu KL; Wu KL; Tsai HM; Chen ML; Chen YW; Hsieh W; Lin CM; Wang Y
    Sci Rep; 2017 Apr; 7():46301. PubMed ID: 28387350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is immunotherapy an opportunity for effective treatment of drug addiction?
    Zalewska-Kaszubska J
    Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immunopharmacotherapy against drugs of abuse.
    Meijler MM; Matsushita M; Wirsching P; Janda KD
    Curr Drug Discov Technol; 2004 Jan; 1(1):77-89. PubMed ID: 16472221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
    Danger Y; Gadjou C; Devys A; Galons H; Blanchard D; Folléa G
    J Immunol Methods; 2006 Feb; 309(1-2):1-10. PubMed ID: 16412457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-(+)-methamphetamine monoclonal antibody antagonists designed to prevent the progression of human diseases of addiction.
    Gentry WB; Rüedi-Bettschen D; Owens SM
    Clin Pharmacol Ther; 2010 Sep; 88(3):390-3. PubMed ID: 20668443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use.
    Stevens MW; Tawney RL; West CM; Kight AD; Henry RL; Owens SM; Gentry WB
    MAbs; 2014; 6(2):547-55. PubMed ID: 24492290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
    Carroll FI; Abraham P; Gong PK; Pidaparthi RR; Blough BE; Che Y; Hampton A; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2009 Nov; 52(22):7301-9. PubMed ID: 19877685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of distinct chemical structures for the development of a methamphetamine vaccine.
    Moreno AY; Mayorov AV; Janda KD
    J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing immunotherapies to thwart drug abuse.
    Peterson EC; Owens SM
    Mol Interv; 2009 Jun; 9(3):119-24. PubMed ID: 19592672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
    Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
    J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for treating methamphetamine, heroin and cocaine use disorders.
    Xiaoshan T; Junjie Y; Wenqing W; Yunong Z; Jiaping L; Shanshan L; Kutty Selva N; Kui C
    Drug Discov Today; 2020 Mar; 25(3):610-619. PubMed ID: 31419495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.
    Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R
    J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in Immunotherapy for Drug Addiction].
    Chen L; Ru Q; Zhou M; Wu YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):116-123. PubMed ID: 33663672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.